Publications

Peer-reviewed publications

  1.  Lilleker JB, Vencovsky, J, Wang G, Wedderburn LR, Diedrichson L, Schmidt J, Jordan P, Benveniste O, Danieli MG, Danko K, Thuy P, Vazquez-Del Mercado M, Molberg O, Andersson H, De Paepe B, De Bleeker J, Maurer B, Pipitone N, McHugh NJ, Betteridge Z, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H. The EuroMyositis Registry: An International Characterisation of Myositis. In preparation
  2. James B Lilleker1,2, Patrick Gordon3, Robert G Cooper4,5, Janine A Lamb4, Mark E Roberts1, Paula Jordan6, Hector Chinoy2,7. On behalf of the UK Myositis Network (UKMYONET) and Myositis UK. A patient-centred standard of care for adults with myositis. In preparation
  3. Oldroyd A, Newton L, Sergeant J, New P, Ollier W, McHugh NJ, Cooper RG, Chinoy H, Increased mortality in the Idiopathic Inflammatory Myopathies: Results from long term follow-up of the UKMYONET cohorts. In preparation
  4. Oldroyd A, Parker B, Bruce I, New P, Cooper RG, Chinoy H. Early features of Atherosclerosis are evident in adult Idiopathic Inflammatory Myopathy - A UK cross-sectional case control study. In preparation.
  5. Oldroyd A, Betteridge Z, McHugh NJ, Cooper RG, Chinoy H. Associations with anti-TIF1g antibodies and time to cancer in dermatomyositis. In preparation
  6. Rutkowski D, Chinoy H, Warren R. The potential benefits of Certolizumab in Chronic Plaque Psoriasis. In preparation
  7. Anthony A. Amato1, Umesh Badrising2, Olivier Benveniste3, Merrilee Needham4, Hector Chinoy5, Min Wu6, Barbara Koumaras6, Ana de Vera7, Dimitris A. Papanicolaou6, Michael G Hanna8, on behalf of the RESILIENT Study Group. RESILIENT: A Randomized, Double-Blind, Placebo-Controlled Study of Bimagrumab in Patients with Sporadic Inclusion Body Myositis. In preparation
  8. Ingrid E Lundberg1, Anna Tjärnlund1*, Matteo Bottai2*, Victoria P Werth3, Clarissa Pilkington4, Marianne de Visser5, Lars Alfredsson2, Anthony A Amato6, Richard J Barohn7, Matthew H Liang8, Jasvinder A Singh9, Rohit Aggarwal10, Snjolaug Arnardottir11, Hector Chinoy12, Robert G Cooper13, Katalin Dankó14, Mazen M Dimachkie7, Brian M Feldman15, Ignacio Garcia-De La Torre16, Patrick Gordon17, Taichi Hayashi18, James D Katz19, Hitoshi Kohsaka20, Peter A Lachenbruch21, Bianca A Lang22, Yuhui Li23, Chester V Oddis10, Ann M Reed24, Lidia Rutkowska-Sak25, Helga Sanner26, Albert Selva-O'Callaghan27, Yeong Wook Song28, Katarzyna Swierkocka29, Jiri Vencovsky30, Steve Ytterberg24, Frederick W Miller31§, Lisa G Rider. EULAR/ACR Classification Criteria for Idiopathic Inflammatory Myopathies. In preparation
  9. Matteo Bottai1, Anna Tjärnlund2, Giola Santoni3, Victoria P Werth4, Clarissa Pilkington5, Marianne de Visser6, Lars Alfredsson2, Anthony A Amato7, Richard J Barohn8, Matthew H Liang9, Jasvinder A Singh10, Rohit Aggarwal11, Snjolaug Arnardottir12, Hector Chinoy13, Robert G Cooper14, Katalin Dankó15, Mazen M Dimachkie8, Brian M Feldman16, Ignacio Garcia-De La Torre17, Patrick Gordon18, Taichi Hayashi19, James D Katz20, Hitoshi Kohsaka21, Peter A Lachenbruch22, Bianca A Lang23, Yuhui Li43, Chester V Oddis11, Ann M Reed25, Lidia Rutkowska-Sak26, Helga Sanner27, Albert Selva-O'Callaghan28, Yeong Wook Song29, Katarzyna Swierkocka30, Jiri Vencovsky31, Steve Ytterberg25, Frederick W Miller32, Lisa G Rider32, Ingrid E Lundberg. EULAR/ACR Classification Criteria for Idiopathic Inflammatory Myopathies: A Methodology Report. In preparation
  10. ZE Betteridge, H Chinoy, 3J Vencovsky, 4J Winer, 5M Lewis, 6I.E Lundberg, 7K Danko, 8RG Cooper, 1NJ McHugh, UKMYONET. Identification of a Novel Autoantigen Eukaryotic Initiation Factor 3 Associated with Polymyositis.In preparation
  11. L Howells1, A Chisholm1, 3, S Cotterill2, H Chinoy, RB Warren1, C Bundy. The impact of disease severity, illness beliefs and coping strategies on outcomes in psoriatic arthritis. Arthritis Care Research. Under revision
  12. Akshay Hindocha, Peter Klimiuk, Mark E. Roberts, Piyali Pal, Hanns Lochmüller, Hector Chinoy. Co-presentation of Adult-Onset Systemic Lupus Erythematosus and Nemaline Myopathy: A Case Report.
  13. Lilleker JB, Guy M, Roberts ME, Lamb JA, Cooper RG, Chinoy H. Muscle enzyme assays in the Idiopathic Inflammatory Myopathies: quantifying disease activity and screening for cardiac involvement. Rheumatology. Submitted
  14. Rider, Lisa; Ruperto, Nicolino; Pistorio, Angela; Erman, Brian ; Bayat, Nastaran; Lachenbruch, Peter; Rockette, Howard; Feldman, Brian; Huber, Adam; Hansen, Paul; Oddis, Chester; Lundberg, Ingrid E.; Amato, Anthony; Chinoy, Hector; Cooper, Robert; Chung, Lorinda; Danko, Katalin; Fiorentino, David; García-De La Torre, Ignacio; Reed, Ann; Song, Yeong Wook; Cimaz, Rolando; Cuttica, Ruben; Pilkington, Clarissa; Martini, Alberto; van der Net, Janjaap; Maillard, Susan; Miller, Frederick; Vencovsky, Jiri; Aggarwal, Rohit. 2016 Development of Adult Dermatomyositis and Polymyositis and Juvenile Dermatomyositis Response Criteria--Methodological Aspects. Rheumatology 2017. Accepted
  15. Aggarwal, Rohit; Rider, Lisa; Ruperto, Nicolino; Bayat, Nastaran; Feldman, Brian; Oddis, Chester; Amato, Anthony; Chinoy, Hector; Cooper, Robert; Dastmalchi, Maryam; Fiorentino, David; Isenberg, David; Katz, James; Mammen, Andrew; de Visser, Marianne; Ytterberg, Steven; Lundberg, Ingrid E.; Chung, Lorinda; Danko, Katalin; García-De La Torre, Ignacio; Song, Yeong Wook; Villa, Luca; Rinaldi, Mariangela ; Rockette, Howard; Lachenbruch, Peter; Miller, Frederick; Vencovsky, Jiri. 2016 Criteria for Minimal and Moderate Clinical Response for Adult Dermatomyositis and Polymyositis: ACR EULAR IMACS PRINTO Collaborative Initiative. Arthritis and Rheumatology 2017. Accepted
  16. Jani M, Dixon WG, Kersley-Fleet L, Bruce IN, Chinoy H, Barton A, Lunt M, Watson K; BSRBR-RA*.; BSRBR-RA Control Centre Consortium*., Symmons DP, Hyrich KL. Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open. 2017 Jan 17;3(1):e000314. doi: 10.1136/rmdopen-2016-000314
  17. Lilleker J.B.2*, Rietveld A. 3*, Pye S. R., Mariampillai K., Benveniste O., Peeters M. T. J., Miller J.A. L., Hanna M.G., Machado P.M., Parton M.J., Gheorghe K.R., Badrising U. A., Lundberg I.E., Sacconi S., Herbert M.K., McHugh N.J., Lecky B. R. F., Brierley C., Hilton-Jones D., Lamb J.A., Roberts M.E., Cooper R.G., Saris C. G. J., Pruijn G. J. M., Chinoy H.*, van Engelen B. G. M*. Cytosolic 5′-nucleotidase 1a autoantibody profile and clinical characteristics in inclusion body myositis. Ann Rheum Dis. 2017 Jan 25. pii: annrheumdis-2016-210282. doi: 10.1136/annrheumdis-2016-210282. [Epub ahead of print] *joint last author
  18. Rothwell S, Cooper RG, Lundberg IE, Gregersen PK, Hanna MG, Machado PM, Herbert MK, Pruijn GJM, Lilleker JB, Roberts ME, Bowes J, Seldin MF, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Platt H, Molberg Ø, Benveniste O, Radstake TRDJ, Doria A, De Bleecker J, De Paepe B, Gieger C, Meitinger T, Winkelmann J, Amos CI, Ollier WE, Padyukov L, Lee AT, Lamb JA*, Chinoy H*. Immune-array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity across the Disease Spectrum. Arthritis Rheumatol. 2017 Jan 13. doi: 10.1002/art.40045. [Epub ahead of print] *joint last author
  19. Das J, Chinoy H, Dick J, Matthews R, Roberts M. A literature review of eosinophilic fasciitis with an illustrated case. Curr Rheumatol Rev. 2016 Oct 7. [Epub ahead of print] PubMed PMID: 27839505
  20. Jani M, Gavan S, Chinoy H, Dixon WG, Harrison B, Moran A, Barton A, Payne K. A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice. Rheumatology (Oxford). 2016 Aug 29. pii: kew292. [Epub ahead of print] PubMed PMID: 27576368.
  21. Jani M, Isaacs JD, Morgan AW, Wilson AG, Plant D, Hyrich KL, Chinoy H*, Barton A*. Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. Rheumatology (Oxford). 2016 Aug 25. pii: kew299. [Epub ahead of print] PubMed PMID: 27565176.
  22. Murphy SM, Lilleker JB, Helliwell P, Chinoy H. The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome. Rheumatology (Oxford). 2016 Aug 21. pii: kew296. [Epub ahead of print] PubMed PMID: 27550295.
  23. Akram Q, Roberts ME, Oddis CV, Herrick AL, Chinoy H. Rituximab induced neutropenia in a patient with inflammatory myopathy and systemic sclerosis overlap disease. Reumatologica 2016; 54,1:35-37 doi: 10.5114/reum.2016.58760
  24. Parkes JE, Rothwell R, Day PJ, McHugh NJ, Betteridge ZE, Cooper RG, Ollier WE, Chinoy H*,Lamb JA* and the Myositis Genetics Consortium (MYOGEN). Systematic Protein-Protein Interaction and Pathway Analyses in the Idiopathic Inflammatory Myopathies; Arthritis Res Ther. 2016 Jul 7;18(1):156. doi:10.1186/s13075-016-1061-7. PubMed PMID: 27388770 *Joint last author
  25. Kavanaugh A, McInnes IB, Mease PJ, Hall S, Chinoy H, Kivitz AJ, Wang Z, Mpofu S. Efficacy of  Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumour Necrosis Factor Inhibitor Therapy Use: 52-week Results from the Randomised Placebo-controlled FUTURE-2 Study. J Rheumatol 2016 Jun 15. pii: jrheum.160275. [Epub ahead of print] PubMed PMID: 27307536
  26. Jani M, Isaacs JD, Morgan AW, Wilson AG, Plant D, Hyrich KL, Chinoy H*, Anne Barton* on behalf of BRAGGSS. High Frequency of Anti-Drug Antibodies and Association of Random Drug Levels with Efficacy in Certolizumab Pegol Treated Patients with Rheumatoid Arthritis: Results from the BRAGGSS Cohort. Ann Rheum Dis 2016 May 31. pii:annrheumdis-2015-208849. doi: 10.1136/annrheumdis-2015-208849. [Epub ahead of print]*Joint last author
  27. Tansley S, Shaddick G, Christopher-Stine L, Sharp C, Dourmishev L, Maurer B, Chinoy H*,  McHugh NJ*. Developing Standardised Treatment for Adults with Myositis and different Phenotypes: an international survey of current prescribing preferences. Clin Exp Rheumatol. 2016 May 31. [Epub ahead of print] *Joint last author
  28. Abeygunaratne T, Herrick A, Chinoy H, Sowden E, Choudhury J, Sinha S. Simple tool in a complex case: use of the nailfold capillaroscopy. Kidney Int. 2016 May;89(5):1168.
  29. Chisholm A, Pearce CJ, Chinoy H, Warren RB, Bundy, C. Distress, misperceptions, poor coping and suicidal ideation in psoriatic arthritis: a qualitative study. Rheumatology (Oxford). 2016 Mar 8. pii: kew009. [Epub ahead of print]
  30. Lazarewicz K, Brockback J, Chinoy H. Pheochromocytoma in association with focal dermatomyositis. Rheumatology
  31. Akram Q, Chinoy H. Scalp Necrosis Associated with Giant-Cell Arteritis. N Engl J Med. 2016 Feb 11;374(6):e6.
  32. Rothwell S, Cooper RG, Lundberg IE, Miller FW, Gregersen PK, Bowes J, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Hanna MG, Machado PM,Pachman LM, Reed AM, Rider LG, Cobb J, Platt H, Molberg Ø, Benveniste O, Mathiesen P, Radstake T, Doria A, De Bleecker J, De Paepe B, Maurer B, Ollier WE,Padyukov L, O'Hanlon TP, Lee A, Amos CI, Gieger C, Meitinger T, Winkelmann J, Wedderburn LR, Chinoy H*, Lamb JA*; Myositis Genetics Consortium. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis. 2016 Aug;75(8):1558-66. doi: 10.1136/annrheumdis-2015-208119. Epub 2015 Sep 11. *Joint last author
  33. Jani M, Chinoy H, Warren RB, Griffiths CEM, Plant D, Fu B, Morgan AW, Wilson AG, Isaacs JD, Hyrich KL, Barton A; BRAGGSS. Clinical utility of random anti-TNF drug level testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis. Arthritis Rheumatol. 2015 May;67(8):2011-9. Erratum in: Arthritis Rheumatol. 2015 Nov;67(11):3096.
  34. Miller FW, Chen W, O'Hanlon TP, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TR, Isenberg DA, Chinoy H, Ollier WE, Scheet P, Peng B, Lee A, Byun J, Lamb JA, Gregersen PK, Amos CI. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun. 2015 Oct;16(7):470-80. doi: 10.1038/gene.2015.28. Epub 2015 Aug 20.
  35. Moore S, Symmons DP, DuPlessis D, Chinoy H. Amyloid myopathy masquerading as polymyositis. Clin Exp Rheumatol 2015 Jul-Aug;33(4):590-1. 
  36. Bakkour W, Purssell H, Chinoy H, Griffiths CE, Warren RB. The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures. J Eur Acad Dermatol Venereol. 2015 Mar 2. doi: 10.1111/jdv.12997. [Epub ahead of print]
  37. Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld A, Lundberg IE, Chinoy H, Lamb JA, Cooper RG, Roberts M, Badrising UA, De Bleecker JL, Machado PM, Hanna MG, Plestilova L,  Vencovsky J, van Engelen BG, Pruijn GJM. Disease-specificity of autoantibodies to cytosolic 5’-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Ann Rheum Dis. 2016 Apr;75(4):696-701.doi: 10.1136/annrheumdis-2014-206691. Epub 2015 Feb 24. PubMed PMID: 25714931;
  38. Carr DF, Alfirevic A, Johnson R, Chinoy H, van Staa T, Pirmohamed
  39. Alfirevic A, Neely D, Armitage J, Chinoy H, Cooper RG, Laaksonen R, Carr DF, Bloch KM, Fahy J, Hanson A, Yue QY, Wadelius M, Maitland-van Der Zee AH, Voora D, Psaty BM, Palmer CN, Pirmohamed M. Phenotype Standardization for Statin-Induced Myotoxicity. Clin Pharmacol Ther. 2014 Oct;96(4):470-476. doi: 10.1038/clpt.2014.121.
  40. Jani M, Massey J, Wedderburn LR, Vencovsky J, Danko K, Lundberg IE, Padyukov L, Selva-O'Callaghan A, Radstake T, Platt H, Warren RB, Griffiths CE, Lee A, Gregersen PK, Miller FW, Ollier WE, Cooper RG, Chinoy H*, Lamb JA*; and EUMYONET. Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. Ann Rheum Dis. 2014 Sep;73(9):1750-2. doi: 10.1136/annrheumdis-2014-205440. *Joint last author
  41. Jani M, Macphie E, Rao C, Moore S, Mirjafari H, McLoughlin Y, Chinoy H, Shah P. Effectiveness of switching between biologics in psoriatic arthritis- results of a large regional survey. Clin Med. 2014 Feb;14(1):95-6. doi: 10.7861/clinmedicine.14-1-95.
  42. Coates LC, Walsh J, Haroon M, Fitzgerald O, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS. Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1410-6. doi: 10.1002/acr.22284.
  43. Coates LC, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS. Psoriatic arthritis screening tools - study design and methodologic challenges - reply from authors. Br J Dermatol. 2014 Apr;170(4):995-6. doi: 10.1111/bjd.12824.
  44. Foulkes A.C., Griffiths C.E., Chinoy H., Warren R.B., Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis. J Dermatolog Treat. 2014 Feb;25(1):61-2.
  45. Miller F.W., Cooper R.G., Vencovsky J., Rider L.G., Danko K., Wedderburn L.R., Lundberg I.E., Pachman L.M., Reed A.M., Ytterberg S.R., Padyukov L., Selva-O’Callaghan A., Radstake T., Isenberg D.A., Chinoy H., Ollier W.E.R., O’Hanlon T.P., Peng B., Lee A., Lamb J.A., Chen W., Amos C.I., Gregersen P.K., Myositis Genetics Consortium. Genome-wide Association Study of Dermatomyositis Reveals Genetic Overlap with other Autoimmune Disorders. Arthritis Rheum. 2013 Dec;65(12):3239-47 doi: 10.1002/art.38137.
  46. Hughes M, Chinoy H. Successful use of tocilizumab in a patient with psoriatic arthritis.Rheumatology (Oxford). 2013 Sep;52(9):1728-9. doi: 10.1093/rheumatology/kes432.
  47. Bhalme M., Hayes S., Norton A., Lal S., Chinoy H., Paine P. Rituximab-associated colitis. Inflamm Bowel Dis. 2013 Mar;19(3):E41-3.
  48. Massey J., Rothwell S., Rusbridge C., Tauro A., Addicott D., Chinoy H., Cooper R.G., Ollier W.E.R., Kennedy L.J.  Association of an MHC Class II haplotype with increased risk of polymyositis in Hungarian Vizsla dogs. PLoS One. 2013;8(2):e56490.
  49. Coates L.C., Aslam T., Burden A.D., Burden-The E., Caperon A.R., Cerio R., Chattopadhyay C., Chinoy H., Goodfield M.J.D., Kay L., Kirkham B.W., Lovell C.R., Marzo-Ortega H., McHugh N.J., Murphy R., Pitzalis C. Reynolds N.J., Smith C.H., Stewart E.J.C., Warren R.B., Waxman R., Wilson H.E., Helliwell P.S. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol. 2013 Apr;168(4):802-807.
  50. Chinoy H., Li, C., Platt H., Fertig N., Varsani H., Gunawardena H., Betteridge Z., Oddis C.V., McHugh N.J., Wedderburn L.R., Ollier W.E.R., Cooper R.G. Genetic Association Study of NF-κB genes in UK Caucasian Adult and Juvenile Onset Idiopathic Inflammatory Myopathy. Rheumatology 2012;51(5):794-799
  51. Chinoy H., Adimulam, S., Marriage F., New P., Vincze M., Zilahi E., Kapitány A.., Gyetvai A., Ekholm L., Novota P., Remakova M., Charles P., McHugh N.J., Padyukov L., Alfredsson L., Vencovsky J., Lundberg I. E., Danko K., Ollier, W.E., Cooper, R.G. The interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 2012 Jun;71(6):961-5
  52. Gompels L.L., Chinoy H., Devakumar V., Bax D.E., Mackworth-Young C.G., Academic Training in Rheumatology in 2009: A UK Trainee Survey. Clinical Medicine 2011:11(5):434-7
  53. Mercer L.K., Moore T.L., Chinoy H., Murray A.K., Vail A., Cooper R.G., Herrick A.L. Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy; Rheumatology 2010: 49(9):1699-705.
  54. Betteridge Z., Gunawardena H., Chinoy H., North J., Ollier W.E.R., Cooper R.G., McHugh N.J.Clinical and HLA-class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK adult-onset Caucasian myositis; Ann Rheum Dis 2009;68(10):1621-5
  55. Chinoy H., Payne D., Poulton K.V., Fertig N., Betteridge Z., Gunawardena H., Davidson J.E., Oddis C.V., McHugh N.J., Wedderburn L.R., Ollier W.E., Cooper R.G. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology 2009;48(10):1213-7
  56. Gunawardena H., Wedderburn L.R., Chinoy H., Betteridge Z., North J., Ollier W.E.R., Cooper R.G.,Oddis C.V., Ramanan A.V., Davidson J.E., McHugh N.J.Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis; Arthritis Rheum 2009;60(6):1807-14
  57. Chinoy H., Salway F., Fertig N., Ollier W.E.R., Cooper R.G. Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy; Rheumatology 2009;48(5):591-2.
  58. Chinoy H., Platt H., Lamb J.A., Betteridge Z., Gunawardena H., Fertig N., Varsani H., Davidson J., Oddis C.V., McHugh N.J., Wedderburn L.R., Ollier W.E.R., Cooper R.G. The PTPN22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients; Arthritis Rheum 2008;58(10):3247-3254.
  59. Gunawardena H., North J., Wedderburn L.R., Davidson J.E., Betteridge Z., Dunphy J., Chinoy H., Cooper R.G., McHugh N.J. Clinical associations of autoantibodies to a p155/140 kDa doublet in adult and juvenile dermatomyositis; Rheumatology 2008;47(3):324-8.
  60. Wedderburn L.R., McHugh N.J., Chinoy H., Cooper R.G., Salway F., Ollier W.E.R., McCann L.J., Varsani H., Dunphy J., North J., Davidson J.E. HLA haplotype and autoantibody associations in children with juvenile dermatomyositis and scleroderma overlap; Rheumatology 2007;46(12):1786-91.
  61. Chinoy H., Salway F., John S., Fertig N., Tait B.D., Oddis C.V., Ollier W.E.R., Cooper R.G. Tumour necrosis factor alpha single nucleotide polymorphisms are not independent of HLA class I and II in the idiopathic inflammatory myopathies; Rheumatology 2007;46(9):1411-6.
  62. Chinoy H., Salway F., John S., Fertig N., Tait B.D., Oddis C.V., Ollier W.E.R., Cooper R.G. Interferon-gamma and interleukin-4 gene polymorphisms in UK Caucasian idiopathic inflammatory myopathy patients; Ann Rheum Dis 2007;66(7):970-3.
  63. Chinoy H., Fertig N., Oddis C.V., Ollier W.E.R., Cooper R.G. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis; Ann Rheum Dis 2007;66(10):1345-9.
  64. Chinoy H., Salway F., Fertig N., Tait B.D., Oddis C.V., Ollier W.E.R., Cooper R.G. Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis/dermatomyositis in UK Caucasians; Rheumatology 2007;46(4):604-7.
  65. Edge K., Chinoy H., Cooper R.G. Serum alanine aminotransferase elevations correlate with serum creatine phosphokinase levels in myositis. Rheumatology 2006;45(4):487-8.
  66. Chinoy H., Salway F., Fertig N., Shephard N., Tait B.D., Thomson W., Isenberg D.A., Oddis C.V., Silman A.J., Ollier W.E.R., Cooper R.G. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype; Arthritis Research & Therapy 2006;8:R13.
  67. Chinoy H. & McKenna F. Wegener’s granulomatosis & rheumatoid arthritis overlap. Rheumatology 2002;41(5):588-9.

Peer-reviewed publications as part of consortia

  1. Gang Q, Bettencourt C, Machado PM, Brady S, Holton JL, Pittman AM, Hughes D,Healy E, Parton M, Hilton-Jones D, Shieh PB, Needham M, Liang C, Zanoteli E, de Camargo LV, De Paepe B, De Bleecker J, Shaibani A, Ripolone M, Violano R, Moggio M, Barohn RJ, Dimachkie MM, Mora M, Mantegazza R, Zanotti S, Singleton AB, Hanna MG, Houlden H; Muscle Study Group and The International IBM Genetics Consortium. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiol Aging. 2016 Aug 8. pii: S0197-4580(16)30161-0. doi:10.1016/j.neurobiolaging.2016.07.024. [Epub ahead of print] PubMed PMID:27594680.
  2. van der Stap DK, Rider LG, Alexanderson H, Huber AM, Gualano B, Gordon P, van der Net J, Mathiesen P, Johnson LG, Ernste FC, Feldman BM, Houghton KM,Singh-Grewal D, Kutzbach AG, Munters LA, Takken T; International Myositis Assessment and Clinical Studies Group. Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies. J Rheumatol. 2016 Jan;43(1):169-76.
  3. McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landewé R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G,Patekar M, Mpofu S; FUTURE 2 Study Group. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis(FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015 Sep 19;386(9999):1137-46. doi: 10.1016/S0140-6736(15)61134-5.
  4. Gang Q, Bettencourt C, Machado PM, Fox Z, Brady S, Healy E, Parton M, Holton JL, Hilton-Jones D, Shieh PB, Zanoteli E, De Paepe B, De Bleecker J, Shaibani A,  Ripolone M, Violano R, Moggio M, Barohn RJ, Dimachkie MM, Mora M, Mantegazza R, Zanotti S, Hanna MG, Houlden H; Muscle Study Group and the International IBM Genetics Consortium. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiol Aging. 2015 Apr;36(4):1766.e1-3. doi: 10.1016/j.neurobiolaging.2014.12.039. Epub 2015 Jan 14.
  5. Cordingley L, Prajapati R, Plant D, Maskell D, Morgan C, Ali FR, Morgan AW, Wilson AG, Isaacs JD; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Barton A. Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 Jun;66(6):861-8. doi: 10.1002/acr.222 
  6. Yarwood A, Viatte S, Plant D, Morgan AW, Isaacs J, Wilson AG, Hyrich K, Eyre S, Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS). Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approach.Ann Rheum Dis. 2014 May;73(5):938-40. doi: 10.1136/annrheumdis-2013-20444 
  7. Bluett J, Ibrahim I, Plant D, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD; BRAGGSS, Barton A. Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Pharmacogenomics J. 2014 Apr;14(2):171-5. doi: 10.1038/tpj.2013.26.
  8. Plant D, Ibrahim I, Lunt M, Eyre S, Flynn E, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD; BRAGGGSS, Barton A. Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Res Ther. 2012 Oct 7;14(5):R214.

Editorials

  1. Chinoy H, Cooper RG. Exploring new mechanisms of weakness-induction, further dissection of clinical phenotypes and identification of new biomarkers in the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2015 Nov;27(6):577-9. doi: 10.1097/BOR.0000000000000223.
  2. Chinoy, H, Cooper, R.G. Editorial: collaborative international research leads to new biomarkers for diagnosis and prediction of outcome in the idiopathic inflammatory myopathy spectrum. Curr Opin Rheumatol. 2013 Nov;25(6):726-8.
  3. Warren RB, Chinoy H. Ustekinumab for psoriatic arthritis: close to the PSUMMIT?
  4. Warren R.B., Helliwell P.S., Chinoy H. Time for a “joint” approach? [Editorial]. Br J Dermatol. 2013 Br J Dermatol. 2013 Apr;168(4):683-4. 

Reviews

  1. Rothwell S, Lamb JA, Chinoy H. New developments in genetics of myositis. Curr Opin Rheumatol. 2016 Jul 27. [Epub ahead of print] PubMed PMID: 27466937.
  2. Parkes JE, Day PJ, Chinoy H, Lamb JA. The role of microRNAs in the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2015 Nov;27(6):608-15. doi:10.1097/BOR.0000000000000225.
  3. Hughes, M., Lillleker, J., Herrick, A.L. Chinoy, H. Cardiac Troponin Testing in Idiopathic Inflammatory Myopathies and Systemic Sclerosis-Spectrum Disorders: Biomarkers to Distinguish between Primary Cardiac Involvement and Low Grade Skeletal Muscle Disease Activity. Ann Rheum Dis. 2015 May;74(5):795-8. 
  4. Rothwell S, Cooper RG, Lamb JA, Chinoy H. Strategies for evaluating idiopathic inflammatory myopathy disease susceptibility genes. Curr Rheumatol Rep. 2014 Oct;16(10):446.
  5. Jani M, Barton A, Warren RB, Griffiths CE, Chinoy H. The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatology (Oxford). 2014 Feb;53(2):213-22.
  6. Rothwell, S., Cooper, R.G., Lamb, J.A., Chinoy, H. Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2013 Nov;25(6):735-41.
  7. Hamann P, Cooper R, McHugh N, Chinoy H. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum. Autoimmun Rev. 2013 Oct;12(12):1177-81. doi: 10.1016/j.autrev.2013.07.001.
  8. Chinoy H., Lamb, J.A. Ollier, W.E.R., Cooper, R.G. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Research & Therapy 2011. May 26;13(3):216.
  9. Chinoy H., Lamb J.A., Ollier W.E., Cooper R.G. An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond; Curr Opin Rheumatol 2009;21(6):588-93.
  10. Madan V., Chinoy H., Cooper R.G., Griffiths C.E. Defining cancer-risk in dermatomyositis. Part 1; Clin Exp Derm 2009;34(4):451-5.
  11. Madan V., Chinoy H., Cooper R.G., Griffiths C.E. Defining cancer-risk in dermatomyositis. Part 2. Assessing diagnostic usefulness of myositis serology; Clin Exp Derm 2009 ;34(5):561-5.
  12. Chinoy H., Ollier W.E.R., Cooper R.G. Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies? Curr Opin Rheumatol 2004 Nov;16(6):707-13.

Book chapters

  1. Cooper R.G., Chinoy H., Lundberg I. Gene–Gene and Gene–Environment Interactions in Defining Risk and Spectrum of Phenotypes in Idiopathic Inflammatory Myopathies.Between the Lines of Genetic Code :Genetic Interactions in Understanding Disease and Complex Phenotypes. Ed Padyukov (Elsevier) 2014:115-132
  2. Chinoy H., Cooper, R.G. Polymyositis and Dermatomyositis in adults. Oxford Textbook of Rheumatology, 4th edition, ed Watts R., Conaghan P., Denton C., Foster H., Isaacs J., Müller-Ladner U. (Oxford) 2013 (updated online, 2014, 2015)
  3. Lundberg I., Cooper R.G., Chinoy H. Polymyositis and dermatomyositis. EULAR Textbook on Rheumatic Diseases, 1st edition, Bijlsma H. (ed) (Springer) 2012
  4. Chinoy H., Ollier W.E.R., Cooper R.G. The Genetics of Myositis (Myositis, facts, feelings and future hopes, 2nd edition, Thoughtful Publications), J Fenton [Ed] 2006: 284-293.


I Want Great CareACRBSRRCPMyositis UKMedical Protection SocietyGeneral Medical Council